Dr. Harvey J. Hotchner, MD

Dr. Hotchner practices at Lehigh Valley Hospital-Hazleton in Hazleton, Pennsylvania, part of Thomas Jefferson University.

Dr. Hotchner's NPI, 1932299054, was assigned on October 13, 2006. Dr. Hotchner holds Pennsylvania license MD425738.

Dr. Hotchner's primary practice is Lehigh Valley Hospital-Hazleton, at 700 East Broad Street, Hazleton, PA 18201 in Luzerne County. The practice phone is (570) 501-4000.

Dr. Hotchner's primary practice is Lehigh Valley Hospital-Hazleton in Hazleton, Pennsylvania, part of Thomas Jefferson University. Dr. Hotchner is also affiliated with Lehigh Valley Hospital-Cedar Crest. The medical group on file is Lehigh Valley Physician Group (LVPG). Dmand AI also links Dr. Hotchner to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hotchner practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Hotchner's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Hotchner is licensed in Pennsylvania.

CMS data shows 751 Medicare services from Dr. Hotchner across 4 procedure codes in 2024, all of them office visits, for 225 Medicare patients. Medicare paid $54,887 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 225 Medicare patients who saw Dr. Hotchner in 2024. The largest group is 65 to 74, with 87 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hotchner's median patient age at 68, with 60% women.

In 2024, Dr. Hotchner wrote 650 Medicare Part D claims for 111 patients. 70% of them were for generic drugs. CMS names the drug for 487 of them, across 19 drugs with 11 or more claims each, at $1,234,010 in total drug cost. In 2023, CMS named 515 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Hotchner for performance year 2024, reported as part of a group. Dr. Hotchner accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hotchner as offering telehealth.

CMS Open Payments shows 1,044 general payments to Dr. Hotchner from 61 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 72% of the total. Seagen Inc. paid the most, $3,213.